Anti-obesity medication prescriptions by race/ethnicity and use of an interpreter in a pediatric weight management clinic.

ABSTRACT:

Background

Race/ethnicity and low English proficiency healthcare disparities are well established in the United States. We sought to determine if there are race/ethnicity differences in anti-obesity medication (AOM) prescription rates among youth with severe obesity treated in a pediatric weight management clinic and if, among youth from non-primary English speaking families, there are differences in prescriptions between those using interpreters during visits versus not.

Methods

We reviewed electronic health records of 2- to 18-year-olds with severe obesity seen from 2012 to 2021. Race/ethnicity was self-report, and AOMs included topiramate, stimulants (e.g. phentermine, lisdexamfetamine), naltrexone (±bupropion), glucagon-like peptide-1 agonists, and orlistat. We used gene

SUBMITTER: Bomberg EM 

PROVIDER: S-EPMC9005816 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature